Found 11 articles for: "Therapies"
Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series
July 2026 | Volume 25 | Issue 7 | Case Reports | 659 | Copyright © July 2026
Background: Aromatase inhibitors (AIs) and anti-HER2 therapies improve breast cancer survival, but dermatologic adverse events (dAEs) are underrecognized despite affecting qualit...
Read MoreVitiligo Successfully Treated With Roflumilast Cream 0.3%
July 2026 | Volume 25 | Issue 7 | Case Reports | 662 | Copyright © July 2026
Vitiligo is an autoimmune cutaneous depigmenting disorder that can have significant psychological impacts on affected patients, posing a burden to daily life, which can be even more apparent in p...
Read MoreRacial Differences in Secondary Skin Complications and Timing of Topical Therapy Initiation for Pseudofolliculitis Barbae: A Multicenter Retrospective Database Cohort Study
July 2026 | Volume 25 | Issue 7 | Editorials | e69 | Copyright © July 2026
Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
March 2026 | Volume 25 | Issue 3 | Original Article | 240 | Copyright © March 2026
Androgenetic alopecia (AGA) is a common, progressive form of nonscarring hair loss, affecting both men and women. Its pathogenesis is largely driven by androgenic factors, including elevated dihy...
Read MoreThe Emerging Role of Oncodermatology in a Hemato-Oncology Unit in a Tertiary Hospital
October 2025 | Volume 24 | Issue 10 | Original Article | 1018 | Copyright © October 2025
Background: Our dermatology department consistently receives the largest proportion of internal on-call referrals from the Hematology-Oncology Department. Individuals with hemato...
Read MorePrecision, Research, Progress: Updates in the Management of Pityriasis Rubra Pilaris
August 2025 | Volume 24 | Issue 8 | Features | 833 | Copyright © August 2025
Off-Label Management Strategies for Generalized Granuloma Annulare: What's New?
April 2025 | Volume 24 | Issue 4 | Features | 425 | Copyright © April 2025
Platelet-Rich Plasma Monotherapies for Androgenetic Alopecia: A Network Meta-Analysis and Meta-Regression Study
September 2022 | Volume 21 | Issue 9 | Original Article | 943 | Copyright © September 2022
Introduction: Platelet-rich plasma (PRP) is a commonly used therapeutic option for androgenetic alopecia (AGA). Evidence syntheses for the impact of PRP on AGA has been handicapped by...
Read MoreOnset of Plaque Psoriasis Treatment Responses With Anti-IL-17/IL-23 Biologic Therapies
August 2022 | Volume 21 | Issue 8 | Original Article | 854 | Copyright © August 2022
Background: The impact of psoriasis on quality of life arises from both physical symptoms, such as pain and pruritus, and the psychosocial effects of the often highly visible lesions....
Read MoreHormonal Therapies in the Management of Acne Vulgaris
June 2022 | Volume 21 | Issue 6 | Original Article | 618 | Copyright © June 2022
Acne vulgaris is a multifactorial chronic disorder of the pilosebaceous unit. Established treatments include topical retinoids, antibiotics in mild cases, and oral antibiotics and isotretinoin in mode...
Read MoreNever Give Up! Continued Progress in Development of Topical Therapies for Acne Is a Good Thing
June 2022 | Volume 21 | Issue 6 | Editorials | 571 | Copyright © June 2022
In July 2022, I will reach the milestone of practicing dermatology for 36 years, with 30 years of experience also devoted to clinical research. My background in pharmacy before attending medical schoo...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
